The synthetic triterpenoids CDDO-TFEA and CDDO-Me, but not CDDO, promote nuclear exclusion of BACH1 impairing its activity

Laura Casares, Rita Moreno, Kevin X. Ali, Maureen Higgins, Sharadha Dayalan Naidu, Graham Neill, Lena Cassin, Anders E. Kiib, Esben B. Svenningsen, Alberto Minassi, Tadashi Honda, Thomas B. Poulsen, Clotilde Wiel, Volkan I. Sayin, Albena T. Dinkova-Kostova, David Olagnier, Laureano de la Vega (Lead / Corresponding author)

Research output: Contribution to journal › Article › peer-review

5 Citations (Scopus)

15 Downloads (Pure)

1 Active
2 Finished

3 results

Active
HIPK2 as a Novel Determinant of Tumour Progression and Therapeutic Resistance
de la Vega, L.
Cancer Research UK
1/02/17 → 31/01/24
Project: Research
Finished
Targeting Tumour Cells with Hyperactive NRF2
de la Vega, L.
1/11/18 → 31/10/21
Project: Research
The Role of the Keap1/Nrf2 Pathway in Tumour Metabolic Adaptation (Joint with University of Cambridge and University College London)
Dinkova-Kostova, A.
Cancer Research UK
1/06/15 → 30/04/21
Project: Research